Literature DB >> 25315212

Prevalence and associated factors for HIV-1 transmitted drug resistance in voluntary clients for counseling and testing in Southern Taiwan.

Ya-Wei Weng1, Hung-Chin Tsai2, Susan Shin-Jung Lee3, Kuan-Sheng Wu1, Cheng-Len Sy1, Jui-Kuang Chen1, Yao-Shen Chen4.   

Abstract

BACKGROUND: According to the World Health Organization, HIV-transmitted drug resistance (TDR) is increasing. We analyzed voluntary counseling test data from a hospital in Southern Taiwan to investigate the TDR pattern in Southern Taiwan, the potential relationship between sexual behavior and HIV transmission, and HIV drug-resistant strain transmission.
METHODS: Genotypic resistance assays were performed on treatment-naïve HIV patients recruited from voluntary counseling testing (VCT) in Southern Taiwan from 2007 to 2011. Drug resistance-associated mutations were interpreted with Stanford University HIV Drug Resistance Database HIVdb program. Socio-demographics and sexual activity were recorded from the VCT questionnaire. Logistic regression analysis was used to analyze the risk factors for TDR, and a phylogenetic tree was constructed to elucidate the pattern of HIV drug-resistant strains.
RESULTS: Among the 161 treatment-naïve HIV-infected patients, most were men who reported having sex with men. The overall TDR rate was 10.6%. Patients with a history of sexually transmitted diseases had a 7.8-fold higher risk of becoming infected with genotypic resistant strains.
CONCLUSION: In Southern Taiwan, the HIV TDR rate was 10.6% among those receiving VCT. Our findings suggest that sexual behavior may play an important role in HIV drug-resistant strain transmission.
Copyright © 2014. Published by Elsevier B.V.

Entities:  

Keywords:  Drug resistance; HIV; Sexually transmitted diseases

Mesh:

Year:  2014        PMID: 25315212     DOI: 10.1016/j.jmii.2014.08.002

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN: 1684-1182            Impact factor:   4.399


  6 in total

1.  Frequency of transmitted drug resistance mutations among treatment-naïve HIV-1-infected individuals at a tertiary care centre in South India.

Authors:  Rajesh Kannangai; Shoba David; Vijayanand C Sundaresan; Jaiprasath Sachithanandham; Monika Mani; Ooriapadickal Cherian Abraham; Susanne Alexander Pulimood; Priscilla Rupali; Gopalan Sridharan
Journal:  Mol Diagn Ther       Date:  2015-10       Impact factor: 4.074

2.  High prevalence of HIV-1 transmitted drug resistance and factors associated with time to virological failure and viral suppression in Taiwan.

Authors:  Szu-Wei Huang; Mei-Chen Shen; Wen-Hung Wang; Wei-You Li; Jen-Hsien Wang; Cheng-Yin Tseng; Po-Yu Liu; Lih-Shinn Wang; Yu-Lin Lee; Yi-Ming Arthur Chen; Chun-Yuan Lee; Po-Liang Lu; Sheng-Fan Wang
Journal:  J Antimicrob Chemother       Date:  2021-12-24       Impact factor: 5.790

3.  HIV-1 genotypic drug resistance in patients with virological failure to single-tablet antiretroviral regimens in southern Taiwan.

Authors:  Hung-Chin Tsai; I-Tzu Chen; Susan Shin-Jung Lee; Yao-Shen Chen
Journal:  Infect Drug Resist       Date:  2018-08-03       Impact factor: 4.003

4.  Trend of HIV transmitted drug resistance before and after implementation of HAART regimen restriction in the treatment of HIV-1 infected patients in southern Taiwan.

Authors:  Ya-Wei Weng; I-Tzu Chen; Hung-Chin Tsai; Kuan-Sheng Wu; Yu-Ting Tseng; Cheng-Len Sy; Jui-Kuang Chen; Susan Shin-Jung Lee; Yao-Shen Chen
Journal:  BMC Infect Dis       Date:  2019-08-23       Impact factor: 3.090

5.  Trend of HIV Transmitted Drug Resistance After the Introduction of Single-Tablet Regimens in Southern Taiwan.

Authors:  Hung-Chin Tsai; I-Tzu Chen; Hui-Min Chang; Susan Shin-Jung Lee; Yao-Shen Chen
Journal:  Infect Drug Resist       Date:  2022-09-19       Impact factor: 4.177

6.  HIV-1 integrase strand-transfer inhibitor resistance in southern Taiwan.

Authors:  Hung-Chin Tsai; I-Tzu Chen; Kuan-Sheng Wu; Yu-Ting Tseng; Cheng-Len Sy; Jui-Kuang Chen; Shin-Jung Susan Lee; Yao-Shen Chen
Journal:  Oncotarget       Date:  2018-05-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.